STALICLA SA is a Swiss clinical-stage biopharmaceutical company pioneering Neuro Precision Medicine in neurodevelopmental and neuropsychiatric disorders. With state-of-the-art technology platforms and clinical trials for Autism Spectrum Disorder (ASD) and Substance Use Disorder (SUD), STALICLA is changing the landscape of brain disease treatments.
Neurodevelopmental Disorders: To propel neurodevelopmental research, STALICLA have identified patient subgroups and their matching candidate drugs within Autism Spectrum Disorder using its trailblazing, multi-omics DEPI platform. STALICLA is currently preparing Phase 2 trials for STP1, STALICLA's first patient subgroup-matched precision treatment.
Substance Use Disorder research: STALICLA is working in partnership with the National Institute of Drug Abuse (NIDA) to advance Phase 3 clinical trials for the most clinically advanced drug candidate for cocaine abuse disorder, STP7.
STALICLA is now raising series C funding to advance both verticals. For more information visit: https://stalicla.com.
Company Details
- Employees
- 25
- Founded
- -
- Address
- Campus Biotech Innovation Park, Avenue De Sécheron 15,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://stalicla.com/
- Keywords
- Biotechnology, Neuroscience, Research, Financing research, Autism, Big data, Innovation, Personalized medicine, Neurodevelopmental Disorders, ASD, NDDs.
- HQ
- Genève, Genève
Stalicla Questions
Stalicla's website is http://stalicla.com/
Stalicla's LinkedIn profile is https://ch.linkedin.com/company/stalicla
Stalicla has
25 employees.
View email and phone details for 25
employees at Stalicla.
Stalicla's industry is
Biotechnology Research
Stalicla's top competitors are
Tolremo Therapeutics,
Endogena Therapeutics, Inc.,
Neurosterix,
Muvon Therapeutics Ag,
Forx Therapeutics,
Ionctura,
Araris Biotech Ag,
Synendos Therapeutics Ag,
Haya Therapeutics,
Addex Therapeutics.
Stalicla's categories are Biotechnology Research
Stalicla's founding year is 2017
